Gabrielle DeGravina | CG Capital |
David Dodd | Chairman, President & CEO |
Mark Reynolds | CFO |
Kelly McKee | Chief Medical Officer |
Mark Newman | Chief Scientific Officer |
John Sharkey | Head of Business Development |
Jason Kolbert | Dawson James Securities |
Vernon Bernardino | H.C. Wainwright & Co. |
Joanne Lee | Maxim Group |
Robert LeBoyer | Noble Capital |
Kumar Raja | ROTH Capital |
Jeffrey Kraws | Crystal Research Associates |
Good afternoon and welcome everyone to the GeoVax Fourth Quarter and Full Year 2022 Corporate Update Call. My name is Diego and I will facilitate today's call. With me today are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, Chief Scientific Officer; Dr. Kelly McKee, Chief Medical Officer; and Dr. John Sharkey, Vice President, Business Development.